Riskpilot← Back to searchSign inGet full accessGuldlyckan AB
ABActiveOrg 5562250372Yngves Väg 18General medical practice activities · NACE 8621Est. 19830 employees
Revenue 2024
SEK 200K
0% vs 2023
EBITDA margin
-24.5%
-136% vs 2023
Equity ratio
48.4%
Financial strength
Net profit 2024
SEK -375K
-6350% vs 2023
| Revenue | SEK 200K | +0% |
| EBITDA | SEK -49K | -136% |
| Net profit | SEK -375K | -6350% |
| Total assets | SEK 9,5M | -2% |
| Equity | SEK 4,6M | -8% |
| Employees | 0 | — |
Legal name
Guldlyckan AB
Org number
5562250372
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 februari 1983
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva medicinsk konsultverksamhet samt idka förmedlingstjänst av semesterboende och fastighetsförvaltning samt bedriva försäljning av reklamtexter och reklamidéer och därmed förenlig verksamhet.
Address
Yngves Väg 18
Phone
+4640420077
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 204 | 200 | 200 | 200 | 200 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 106 | 20 | 91 | 138 | −49 |
| Depreciation & amort. | −117 | −161 | −161 | −161 | −161 |
| EBIT | −11 | −141 | −70 | −23 | −210 |
| Net financials | −56 | −55 | −66 | −134 | −165 |
| Profit before tax | 90 | 26 | 448 | 8 | −375 |
| Tax | −21 | −9 | −102 | −2 | −0 |
| Net profit | 69 | 17 | 346 | 6 | −375 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 189 | 10 008 | 9 859 | 9 734 | 9 548 |
| Equity | 4 627 | 4 644 | 4 990 | 4 996 | 4 621 |
| Long-term debt | 3 066 | 3 077 | 3 000 | 3 000 | 4 704 |
| Short-term debt | 1 524 | 1 537 | 1 703 | 1 738 | 224 |
| Total debt | 4 590 | 4 614 | 4 703 | 4 738 | 4 928 |
EBITDA margin
-24.5%
This company
15.8%
Market median
-255% vs market
20202024
Equity ratio
48.4%
This company
38.2%
Market median
+27% vs market
20202024
Return on equity
-8.1%
This company
18.4%
Market median
-144% vs market
20202024
Net profit margin
-187.5%
This company
8.1%
Market median
-2415% vs market
20202024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20202024
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JL | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medisport Holding AB
Guldlyckan AB Board members of Guldlyckan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Lennart Bertil Nilsson | Audit | 0 companies |
| Lena Elisabeth Abrahamsson | Deputy Board Member | 0 companies |
| Per-Anders Abrahamsson | Board of Directors | 0 companies |